Turnover
≈ €130,000 estimated
The accounts state no turnover.
PROCHIPHAR
Lifetime
20 annual accounts with figures on one time axis, 37 filings since 1989peak €790,236 (2022)
€25,930▲ €48,482
lowest -€27,694 (2024)
€8,838▲ €36,532
peak €1.6m (2017)
€955,867▲ 0.9%
€219,459▲ 2.8%
peak 2 FTE (2021)
-not published
Board3 names since 2018
2 directors and 1 other
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Gross margin from -€22,552 to €25,930Back to profit: €8,838Cash from €18,266 to €10,301
Key points
from the 2025 annual accountsFilings
37 annual accounts since 1989
Nine of the last ten came late. The 2019 accounts came latest: 87 days after the end of the period.
Position in the sector
81.3%
Higher solvency than 85% of companies in wholesale trade. Sector median 44.1% · 10,754 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 14,768 companies had the same profile as PROCHIPHAR has now. Each dot stands for 37 companies, two years later.
96.1%
were still trading
3.5%
stopped another way
0.2%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 14,768 companies, not a prediction for PROCHIPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0436168418
2 directors appointed, 1 resignation
Appointments: (chair) and · Resignation: · General meeting of 09-06-2023 · Gazette deed
Capital decrease of €853,000 to €62,000
Capital from €915,000 to €62,000 · Authorised capital up to €238,000 for 5 years · Reappointments: (director) and (director) · General meeting of 29-03-2018 · Gazette deed
First establishment
Rue Bois des Queues 9, Incourt
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| PROCHIPHAR Incourt | €1.2m | €25,930 | 81.3% | - |
| PATRIMOL Stekene | €0.6m | €29,592 | 19.3% | - |
| IMMO VITA Braine-l'Alleud | €0.6m | €26,076 | -5.2% | - |
| PACHECO Braine-l'Alleud | €1.2m | €41,850 | 37.6% | 1.6 |
| Zabriskie Bruges | €0.6m | €22,239 | 92.7% | - |
| ECOPHARMASUPPLY DISTRIBUTION Estaimpuis | €0.6m | €37,492 | 65.0% | - |
| ADOCS Machelen (Brab.) | €0.7m | €45,936 | 66.4% | - |
These companies have the same main activity as PROCHIPHAR: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €593,000 and €1.2m, founded between 1969 and 1997.
Official details
Source: KBO- Status
- Active since 21-12-1988Normal situation
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460and 1 other
- Joint committee
- 321Wholesale distributors of medicines · annual accounts 2023
- Establishment unit
- 2.041.736.1721315 Incourt, since 23-02-1993
- Financial year end
- 31 December
- Peppol
- Reachable since 19-09-2025
Insights on PROCHIPHAR
PROCHIPHAR files the abbreviated format. That format states no turnover. The gross margin fell from €190,011 in 2006 to €25,930 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PROCHIPHAR
- What is the company number of PROCHIPHAR?
- The company number of PROCHIPHAR is 0436.168.418. The VAT number is the same number with BE in front: BE 0436.168.418.
- Where is PROCHIPHAR based?
- The registered office is at Rue Bois des Queues 9, 1315 Incourt.Company details
- What does PROCHIPHAR do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of PROCHIPHAR?
- PROCHIPHAR is a public limited company (NV).
- When was PROCHIPHAR founded?
- PROCHIPHAR was founded on 21-12-1988.
- Is PROCHIPHAR still active?
- Yes, PROCHIPHAR is an active enterprise in the KBO register.
- How many employees does PROCHIPHAR have?
- PROCHIPHAR had an average of 1 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
- Which joint committee does PROCHIPHAR fall under?
- In its 2023 annual accounts, PROCHIPHAR states joint committee 321 (Wholesale distributors of medicines).
- What is the turnover of PROCHIPHAR?
- The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €25,930 and 34 comparable companies (NACE 464). It probably lies between €84,000 and €270,000.
- Is PROCHIPHAR profitable?
- In financial year 2025, PROCHIPHAR made a profit of €8,838.
- Where can I find the annual accounts of PROCHIPHAR?
- PROCHIPHAR filed 37 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PROCHIPHAR due?
- PROCHIPHAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.